About Atin Sharma
Now on the other side of the publications.
Intro Content
FDA approval for CRISPR/Cas9-based therapy for SCD – an accomplishment for science, not for majority of the patients.
The news of the FDA approving the world's first CRISPR/Cas9-based therapy for SCD is all over the internet. This is my opinion on what this achievement means for science and the majority of patients dealing with SCD.
